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The ultimate design of functionally therapeutic engineered tissues and organs will rely on our ability to engineer
vasculature that can meet tissue-specific metabolic needs. We recently introduced an approach for patterning
the formation of functional spatially organized vascular architectures within engineered tissues in vivo. Here,
we now explore the design parameters of this approach and how they impact the vascularization of an en-
gineered tissue construct after implantation. We used micropatterning techniques to organize endothelial cells
(ECs) into geometrically defined ‘‘cords,’’ which in turn acted as a template after implantation for the guided
formation of patterned capillaries integrated with the host tissue. We demonstrated that the diameter of the
cords before implantation impacts the location and density of the resultant capillary network. Inclusion of mural
cells to the vascularization response appears primarily to impact the dynamics of vascularization. We estab-
lished that clinically relevant endothelial sources such as induced pluripotent stem cell-derived ECs and human
microvascular endothelial cells can drive vascularization within this system. Finally, we demonstrated the
ability to control the juxtaposition of parenchyma with perfused vasculature by implanting cords containing a
mixture of both a parenchymal cell type (hepatocytes) and ECs. These findings define important characteristics
that will ultimately impact the design of vasculature structures that meet tissue-specific needs.
Introduction
T issue engineering has yielded significant advance-ments in the treatment of a variety of diseases caused by
tissue damage or dysfunction.1 While highly promising, a
critical limitation in the field is the successful vasculariza-
tion of large tissue constructs.2 In vivo, it is estimated that a
cell must be located within 150–200 mm of the nearest
capillary to survive and function optimally.3 Due to this
constraint, current efforts to implant large engineered tissue
structures are hindered by significant cell death in areas that
exceed this diffusion limit due to insufficient delivery of
oxygen and nutrients and waste removal.1,2 The future
utility of engineered tissues depends on the successful de-
velopment of vascular architectures within the constructs
that mimic the complexity of native tissues and lead to easy
integration with host circulation.
In vivo, native tissue comprised specialized cells and
vasculature embedded within a tissue-specific extracellular
matrix in a highly organized manner. The liver, in particular,
has a precisely defined microarchitecture involving a com-
plex interplay between hepatocyte cords and microvessel
networks that is thought to impact metabolic mass transport
and tissue function.4 Indeed, it is the loss of this architecture
due to replacement by fibrotic tissue and regenerative nod-
ules that defines chronic cirrhosis.5 Successful therapeutic
tissue engineering will rely on our ability to recapitulate
such macrostructural organization by integrating architec-
turally defined vascular networks with tissue-specific cel-
lular structures.
We have recently established a novel approach for cre-
ating functional spatially organized vascular architectures
within engineered tissues in vivo.6 Our approach uses mi-
cropatterning techniques to organize endothelial cells (ECs)
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into geometrically defined ‘‘cords,’’ which in turn act as a
template after implantation for the guided formation of
patterned capillaries that integrate with the host tissue. In
this study, we provide an important insight into the utility of
this method for robustly vascularizing tissue engineering
constructs by exploring which design parameters influence
the ultimate vascularization of the construct. Specifically,
we characterize the effect of cord geometry, mural cell
composition, and EC source on the vascularization response
after implantation. Finally, we demonstrate the ability to
control the geometry of engineered tissue by implanting
cords containing both a parenchymal cell type (hepatocytes)
and ECs, leading to tight juxtaposition of parenchyma with
perfused vasculature following implantation.
Materials and Methods
Fabrication of PDMS templates and preparation
of engineered implants
Endothelial cell cords were micropatterned as previously
described.6,7 Cells (ECs and 10T1/2s at a 50:1 ratio unless
otherwise stated) were suspended in 2.5mg/mL liquid rat
tail collagen type I (BD Biosciences) and centrifuged into
poly(dimethylsiloxane) (PDMS) channels (150 mm channels
unless otherwise stated) pretreated with 0.01% Pluronic F127
(Fig. 1). Excess unpolymerized collagen and cells were re-
moved by dewetting the surface of the substrate. The collagen
was polymerized, a growth medium was added, and con-
structs were incubated at 37C for 4–6 h to enable cord for-
mation. Cords were then removed from the PDMS substrates
by inverting onto a drop of unpolymerized 10mg/mL bovine
fibrin (Sigma-Aldrich). After the fibrin was polymerized, the
PDMS was removed and a second layer of unpolymerized
fibrin added and polymerized to fully encase the cords. The
embedded cords were cut with a 6-mm biopsy punch before
implantation. To include hepatocytes, primary human hepa-
tocytes, J2-3T3 fibroblasts, and endothelial cells were mixed
in a 1:1:1 ratio before centrifugation.
In vivo implantation of constructs
All surgical procedures were conducted according to
protocols approved by the University of Pennsylvania or
Massachusetts Institute of Technology Institutional Animal
Care and Use Committee. Eight-week-old female Nu/nu
nude mice (Charles River) or NCr nude mice (Taconic) were
anesthetized using isoflurane and the constructs were su-
tured to the mesenteric parametrial fat pad. The incisions
were closed aseptically, and animals were administered
0.1mg/mL buprenorphine every 12 h for 3 days following
surgery.
Statistical analysis and quantification
of vascularization parameters
Quantification was performed manually on imaged he-
matoxylin and eosin (H&E) sections using FIJI Open Source
Software. Blood area was quantified by measuring the total
area tissue containing blood within a cord. Measurements
were normalized to average cord area to compensate for
oblique cutting angles. The vessel number was quantified by
counting individual vessels within a cord and then normalized
to the average cord area. The vessel diameter was quantified
by measuring the diameter of individual vessels within a cord.
Sections for quantification were chosen from the center of the
constructs, and a minimum of three sections at least 150mm
apart were quantified per cord. All data are expressed as the
mean– standard error. Statistical significance was determined
using a one-way analysis of variance (ANOVA) followed by
Tukey’s post hoc test for group comparisons.
For more detailed methods, please see Supplementary Data
(Supplementary Data are available online at www.liebertpub
.com/tec).
Results
Endothelial cord diameters can be tailored
to manipulate capillary density and location
within engineered tissue
The ability to tailor vascular location and density within
engineered tissue is essential to meet the varying metabolic
burdens of diverse parenchymal cell types. We have previ-
ously described that preformed cords within a construct
FIG. 1. Microfabrication of cords. Schematic representa-
tion of the processes used to generate cords. Collagen, pink;
cells, blue; fibrin, green. PDMS, poly(dimethylsiloxane).
Color images available online at www.liebertpub.com/tec
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induced rapid vascularization upon implantation.6 In this
study, we explored whether modulating the initial diameter
of the cords impacts the geometry of the resultant vascula-
ture formed in vivo. We implanted tissue constructs con-
taining cords formed from 50, 150, and 500mm PDMS
channels. Upon formation, the cords contracted to roughly
50% of PDMS channel width in average diameters of 25, 75,
and 250 mm (Fig. 2A). All samples were punched with a 6-
mm biopsy punch before implantation to preserve unifor-
mity in length. In all conditions, H&E staining of samples
resected 7 days postimplantation (PI) confirmed the pres-
ence of red blood cells (RBCs) present around the perimeter
of the cords within capillary-like cellular structures (Fig.
2B). Sirius red/Fast green staining demonstrated persistence
of a collagen core within the cords for all conditions (Fig.
2C). The diameter of this collagen core was proportional to
the initial cord diameter for different cord sizes.
To better assess the vascularization response, we quan-
tified the surface area of blood, the total number of vessels,
and the diameter of vessels in H&E-stained sections (Fig.
2D). This quantification suggested that the average vessel
diameter remained relatively constant across all constructs,
with the 500 mm cord condition exhibiting slightly larger
vessels. All vessels in all conditions were small-diameter
vessels that remained within the defined ‘‘capillary’’8
range and appeared to track along the surface perimeter
around the cords. The surface area of blood within a cord
remained similar throughout the conditions with roughly
20–25% of the cord surface containing blood. This finding
indicates that there is more blood, overall, in samples
containing larger cords and less blood in samples con-
taining smaller cords. The number of capillaries per cord
increased with an increasing cord diameter, although this
number decreased per cross-sectional area of cord since the
larger collagen core remained unvascularized. Therefore,
the resultant blood vessels and, hence, blood are more
dense and localized in implants containing small cords and
more dispersed in implants containing larger cords. Over-
all, our data indicate that the diameter of the cords does not
substantially affect the diameter of the resultant vessels,
but strongly determines the location and density of the
resultant vessels and the overall amount of blood present
within an engineered tissue. Therefore, the cord diameter
could be used to tailor the localization and density of
capillaries to meet specific needs for various parenchymal
tissues.
FIG. 2. Cord diameters can be tailored to manipulate capillary density and location within engineered tissue. (A) Phase
images of endothelial cell (EC) cord constructs made from varying PDMS channels (50, 150, and 500 mm) and after removal
from PDMS substrate and embedded within fibrin gel (scale bar, 250 mm). (B) Hematoxylin and eosin (H&E) staining of
implanted tissue containing cords of varying diameters (50, 150, and 500 mm) resected after 7 days in vivo suggests the
presence of blood in small vessels along the perimeter of the cords (scale bar, 50 mm). (C) Sirius red/Fast green staining of
collagen within the cords after harvest (scale bar, 50mm). (D) Quantification of blood area, vessel diameter, and vessel numbers
for varying cord diameters. *p< 0.05 for comparison. Error bars: SEM, n‡ 20, one-way ANOVA followed by Tukey’s post hoc
test. ANOVA, analysis of variance; SEM, standard of the mean. Color images available online at www.liebertpub.com/tec
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Endothelial cells are necessary to drive
the vascularization response in vivo
Many groups have demonstrated that a mixture of mural and
endothelial cells is required for robust vascularization and vi-
ability of randomly cocultured cells within engineered vascular
implants.9–14 It has been hypothesized that the presence of
mural cells increases networking and tubulogenesis of endo-
thelial cells, which in turn aids in anastomosis to the host upon
implantation.10–14 However, because geometrically patterning
endothelial cells into cords results in very rapid networking
in vitro and robust vascularization upon implantation, the
mural cell requirements within the system may be different. To
determine the contribution of mural cells (10T1/2s) to capillary
formation after implantation, cords composed of EC:10T1/2
ratios of 0:1, 1:2, 5:1, 50:1, and 1:0 (holding total cell number
constant) were implanted and resected 7 days PI. The vascu-
larization response appears to require endothelial cells, as H&E
staining of implanted cords of 10T1/2s alone showed no evi-
dence of blood 7 days PI (Fig. 3A). Likewise, H&E staining of
FIG. 3. Endothelial cells in cords are necessary to drive engraftment and integration to host. (A) H&E staining of cords
consisting of various EC:10T1/2 ratios (10T1/2 only, 1:2, 5:1, 50:1, HUVEC only) resected after 7 days in vivo suggests the
presence of blood in small vessels along the perimeter of all cord conditions containing endothelial cells (scale bar, 50mm). (B)
Sirius red/Fast green staining of collagen within the cords after harvest (scale bar, 50mm). (C) Ter-119 (erythrocytes, white),
human-specific CD31 (HUVECs, red), and alpha-smooth muscle actin (a-SMA; pericytes, green) staining positively identify
red blood cells (RBCs) and ECs (arrowheads: individual vessels) and suggest that vessels consist of implanted human
endothelium with perivascular colocalization (scale bar, 50mm). (D) Quantification of blood area, vessel diameter, and vessel
numbers for varying cell ratios. *A p-value of < 0.05 for comparison. Error bars SEM, n‡ 20, one-way ANOVA followed by
Tukey’s post hoc test. HUVEC, human umbilical endothelial cells. Color images available online at www.liebertpub.com/tec
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implanted cords of another commonly used mural source,
primary human mesenchymal stem cells, resected at 7 days PI
did not demonstrate any evidence of blood (Supplementary
Fig. S1). In all other conditions containing endothelial cells
(including those without mural cells), RBCs were present
around the perimeter of the cords within capillary-like cellular
structures (Fig. 3A). Sirius red/Fast green staining confirmed
the presence of collagen within the cords for all conditions
(Fig. 3B).
To confirm the presence of RBCs and human ECs, tissue
sections were immunohistochemically stained for Ter-119,
an erythroid cell marker and human-specific CD31 (Fig. 3C,
arrowheads). Ter-119 staining demonstrated the presence of
RBCs in all conditions containing endothelial cells in lo-
calized patterns matching those previously observed with
H&E staining. Human ECs circumscribed the RBCs and
were found in all conditions containing implanted endo-
thelial cells, suggesting the formation of blood vessels
containing implanted human ECs. Staining for alpha-smooth
muscle actin (a-SMA) revealed the presence of a-SMA-
positive cells in tight association with ECs in all cord con-
ditions, suggesting a pericyte phenotype. Interestingly,
implanted cords containing human umbilical endothelial
cells (HUVECs) only (without 10T1/2s) also stained posi-
tive to the same extent for a-SMA at 7 days PI, suggesting
host invasion of pericyte-like cells upon engraftment.
Quantification (Fig. 3D) demonstrated that the average
vessel diameter remained relatively constant across all cell
ratios with the 100% EC condition exhibiting slightly larger
vessels. The surface area of blood within a cord increased
slightly with the increasing EC ratio, with a significant rise
in the 100% EC condition (from 25% to 50% of total cord
area). The number of capillaries per cord also increased with
the increasing EC ratio. To examine whether the slight
differences in vascularization response were due to vari-
ability in contractility among different cell compositions, we
assessed the cord contractility in vitro for ECs and EC:10T1/
2 at a 1:1 ratio (Supplementary Fig. S2). Our study suggests
that by 4–6 h (time of embedding and implantation), no
differences are detectable that would explain the in vivo
response. Together, these results suggest that ECs are nec-
essary for the vascularization response and the increasing
number of ECs within an implant appears to enhance the
number of vessels and blood within the construct. However,
although the number of ECs has a positive influence on
vascularization, the effect is relatively small as the vascu-
larization response in samples containing 33–98% ECs is
largely comparable. Thus, in a tissue engineering context,
the approach may provide some flexibility to introduce other
cell types while still having sufficient ECs to induce vas-
cularization, although further functional experiments would
be necessary to validate this.
Cords composed of clinically relevant endothelial
cells support the vascularization response
The ultimate goal of tissue engineering is to create clin-
ically viable engineered tissues that can be used therapeu-
tically in human patients. While useful in demonstrating
proof of principal in vascular engineering strategies,
HUVECs are not widely considered a compatible source of
ECs for clinical translation.15 Therefore, the use of clinically
relevant ECs such as human microvascular endothelial cells
(HMVECs) that are easily obtained through patient skin
biopsies or induced pluripotent stem cell-derived ECs (iPS
ECs), which can be isolated and created from patient-
specific cell sources is an important consideration in deter-
mining the translational viability of this approach. To
determine whether more clinically relevant ECs induce a
similar vascularization response as HUVECs, we implanted
HMVECs and iPS ECs and resected 7 and 14 days PI.
Before implantation, iPS ECs were generated based on
previously described protocols16,17 and verified to express
endothelial markers and respond to endothelial-specific
stimuli (Supplementary Fig. S3). The iPS ECs responded to
the proangiogenic gradient by invading the surrounding
matrix as multicellular lumen-containing sprouts (Supple-
mentary Fig. S3A), as previously demonstrated by human
umbilical vein endothelial cells.18 The iPS EC angiogenic
sprouts exhibit classic EC expression of the cell junctional
protein and platelet endothelial cell adhesion molecule
(CD31) and confirmed correct apical–basal polarization, as
indicated by the CD34 apical marker podocalyxin immu-
nofluorescence (Supplementary Fig. S3B).
H&E staining of resected tissues containing HUVEC-only
cords, HMVEC-only cords, and iPS EC cords suggested the
presence of RBCs around the perimeter of the cords at 7
days PI. Large areas of blood were present at 7 days PI and
were surrounded by a fragmented layer of cells, reminiscent
of the pattern observed in leaky vasculature (Fig. 4A). Loose
cellular structures were replaced over time by smaller, more
definitive vessel-like cellular lining stereotypical of mature
microvessels by 14 days PI in all conditions (Fig. 4D). Sirius
red/Fast green staining demonstrated the presence of colla-
gen within the cords for all conditions and time points (Fig.
4B, E). Ter-119 staining confirmed the presence of RBCs in
all conditions and time points in localized patterns matching
those previously observed with H&E staining (Fig. 4C, F,
arrowheads). Human ECs circumscribed the RBCs and were
found in all conditions and time points, suggesting the for-
mation of blood vessels containing implanted ECs. HuCD31
staining also demonstrated the presence of larger vessels in
all cell conditions at 7 days and smaller more capillary-like
vessels at 14 days. The huCD31 staining was slightly less
robust at 14 days in HMVEC and iPS EC conditions, al-
though this did not affect the overall vascularization re-
sponse. Interestingly, although the implanted cords did not
contain an initial population of mural cells, a-SMA-positive
cells were found in tight association with ECs in all con-
ditions and time points. Furthermore, a-SMA-positive
staining appeared to be located on the apical side of the
vessels at 7 days (Fig. 4C, arrowheads) and on the basal side
at 14 days (Fig. 4F, box), possibly suggesting an intravas-
cular host origin of pericyte-like cells upon engraftment and
perfusion. We have previously shown that the vessels in-
duced by EC:10T1/2 cords are extensively perfused.6 To
confirm that this also occurs in the EC-only cords, we per-
formed systemic injections of human-specific lectin (Ulex
europaeus agglutinin 1 [UEA-1]—TRITC) through the tail
vein at 2 weeks following implantation of HUVEC-only
cords. Visualization of cryosections demonstrated that 8 out
of 10 explants contained perfused vessels with human-
specific endothelial cells, similar to the percentage of sam-
ples that contain erythrocytes by histological assessment of
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human CD31 vessels containing Ter199 + blood at this time
point (76%).
Quantification (Fig. 4G) suggests that the vasculariza-
tion response is similar among the different cell types and
that without mural cells, maturation of vessels occurs
within the cords between 7 and 14 days PI, during which
the area of blood within cords decreases, the number of
capillaries per cord increases, and the average vessel di-
ameter decreases. Together, these results suggest that
engineered cords composed of different sources of poten-
tially patient-specific endothelial cells can induce host
vascularization and perfusion, which occur through the
initial formation of large nascent vessels that later lume-
nize and reorganize into smaller, more numerous, and
mature capillaries that are organized around and alongside
the collagen core of the cords.
Hybrid cords of ECs and hepatocytes induce
the formation of patterned engineered tissue
integrated with host vasculature
Because cord formation is drivenbycontractility,6 and fewer
than 50% of the cord may be composed of ECs, we hypothe-
sized that virtually any cell type could be added to the EC
suspension to create hybrid EC/parenchymal cell cords.
Therefore, we next sought to determine whether engineered
tissue containing hepatocytes cocultured with ECs within the
cords themselves would become vascularized. We hypothe-
sized that delivery of hepatocytes in cords may result in better
recapitulation of native tissue architecture, in which he-
patocytes are organized along hepatic sinusoids in cord-like
structures.4 To assess whether endothelial cords would sup-
port primary human hepatocytes after implantation, tissue
FIG. 4. Translational cell types. (A) H&E staining of cords composed of HUVECs, human microvascular endothelial cells
(HMVECs), and induced pluripotent stem cell-derived ECs (iPS ECs) resected after 7 days and (D) 14 days in vivo suggests
the presence of blood in large vessels at 7 days that organize into small capillaries by 14 days (scale bar, 50 mm). (B) Sirius
red/Fast green staining of collagen within the cords resected after 7 days and (E) 14 days in vivo. (C) Ter-119 (erythrocytes,
white), human-specific CD31 (human ECs, red), and a-SMA (pericytes, green) staining positively identify RBCs and ECs
and suggest that vessels consist of implanted human endothelium with perivascular colocalization at 7 days (arrowheads:
individual vessels) and (F) 14 days postimplantation (PI) [arrowheads: individual capillaries, box: a-SMA (pericytes,
green); scale bar, 50 mm]. (G) Quantification of blood area, vessel diameter, and vessel numbers for translational cell types
at different time points. *A p-value of < 0.05 for comparison. Error bars SEM, n ‡ 20, one-way ANOVA followed by
Tukey’s post hoc test. **A p-value of < 0.05 for comparison of each group between time points. Error bars SEM, n‡ 20, t-
test. Color images available online at www.liebertpub.com/tec
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constructs containing human hepatocytes cocultured 1:1 with
HUVECs during cord formation, or hybrid cordswere sutured
to the parametrial fat pad in athymicmice and were compared
with control constructs containing cords made of hepatocytes
alone. Histological assessment of tissues explanted at 7 days
PI revealed the presence of localized cell laden structures
within the fibrin implant that were organized spatially into
patterns mimicking the original position of the implanted
cords (Fig. 5A). Highermagnification elucidated the presence
of RBCs around the perimeter of the cord-like structures in the
hybrid EC/Hep cords, while showing that the Hep-only cords
were devoid of RBCs (Fig. 5B). The peripheral localization of
host vasculature suggested that ECs and Heps self-sorted
within the cord structure, with the ECs migrating to the pe-
rimeter of the cords, and encasing a hepatocyte core. Sirius
red/Fast green staining confirmed that the presence of hepa-
tocytes leads to degradation of the collagen cores of the cords,
particularly in the coculture case, in which no remnants of the
collagen core were evident upon resection (Fig. 5C). Im-
munofluorescent staining for RBCs, human ECs, and viable
hepatocytes (Ter-119, huCD31, and arginase 1 [Arg-1], re-
spectively) demonstrated the presence of perfused neovessels
directly adjacent to hepatocytes in the hybrid cord condition
(Fig. 5D, arrowheads). Furthermore, hepatocytes were lo-
cated no farther than 150mm from the nearest capillary.
Quantification (Fig. 5E) demonstrated the complete lack
of blood and vessels in implanted cords containing hepato-
cytes only. In the hybrid cord condition, on average, 30% of
the cord cross-sectional surface area contained blood. To-
gether, the data suggest that hybrid cords lead to a very
intimate association of neovessels with hepatic tissue within
cords, with no collagen cores.
Discussion
Patterning vascular and parenchymal architectures within
an engineered tissue is currently a critical limitation to our
ability to create complex metabolically active tissues such
as the kidney and liver.19 We recently described a novel
method of patterning endothelial cells into cords that act as a
template for guided vascularization upon implantation
in vivo.6 In this study, we explore the design parameters that
will be important for the future utility of this method for the
vascularization of clinically relevant parenchymal tissues.
First, we demonstrate that a varying cord diameter does not
lead to changes in the caliber of host vessels that form. This
finding is consistent with developmental vasculogenesis,
during which large vessels generally grow in size over a
period of time and do not form spontaneously.20 Instead, we
find that the cord diameter can tailor the location and density
FIG. 5. Hybrid cords. (A) H&E staining of cord-containing tissue constructs resected after 7 days in vivo (boxes: location
of individual cords, arrowheads: individual capillaries around periphery of cord). (B) H&E staining of cords made of
hepatocytes only and hybrid Hep/EC cords resected after 7 days in vivo suggests the presence of blood in small vessels
along the perimeter (dotted line) of the hybrid cords. (C) Sirius red/Fast green staining of collagen within cords suggests that
the hepatocytes largely degrade the collagen core. (D) Ter-119 (erythrocytes, white), human-specific CD31 (HUVECS, red),
and arginase 1 (Arg-1; hepatocytes, green) confirm the presence of blood encased in capillaries lined with human endo-
thelium directly adjacent to viable hepatocytes in the hybrid cord condition (arrowheads: individual capillaries; scale bar,
50 mm). (E) Quantification of blood area, vessel diameter, and vessel numbers for hybrid cords. Error bars SEM, n‡ 20.
Color images available online at www.liebertpub.com/tec
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of capillaries formed in the construct and could therefore be
used to impact engineered tissue vascularization. It is re-
markable that the formation of these vessels occurs in the
absence of any parenchymal demand. Given the endogenous
feedback control systems for regulating capillary density,
we therefore might anticipate that these supraphysiologic
vessels may ultimately destabilize and involute unless a
parenchymal cell were in place to support capillary demand.
Conversely, if a highly metabolic implant ultimately re-
quires a much higher capillary density than can be induced
by our approach, it is possible that the initial gains due to
cords may still leave a tissue undervascularized. Thus, tis-
sue-specific long-term studies will need to be undertaken to
better understand the downstream effects of this approach.
Many different cell types have been used historically in
vascular tissue engineering strategies.9–14,21–23 Initially,
HUVECs alone were implanted, followed by the discovery
that coimplanting HUVECs with a supporting mural cell led
to a more stable vasculature in vivo.11 Others discovered that
preculturing HUVECs and fibroblasts in vitro for a number of
days before implantation led to increased networking and
more robust vascularization in vivo.10,12,13 Additionally,
C3H10T1/2s have been previously shown to increase net-
working behavior and vascularization due to differentiating
into smooth muscle alpha-actin expressing pericytes.24 Col-
lectively, these studies suggest that supporting mural cells are
essential for proper EC networking within randomly seeded
implants in vivo. Based on this literature, our previous studies
used a 1:50 ratio of 10T1/2s and HUVECs.With this ratio, we
found that large leaky vessels formed within the cords by 3
days PI and later reorganized into smaller, more numerous
capillaries around the periphery of the cords. Our quantifi-
cation data suggested that this switch occurred sometime
between 5 and 7 days PI.6 In our studies here, we varied the
percentage of 10T1/2s to elucidate the exact contribution of
mural cells within our system. We found that increasing the
percentage of 10T1/2s within the cords from 2% to 66%
decreased the total blood within the cord slightly. Eliminating
10T1/2s altogether led to the formation of fewer large vessels
at 7 days PI. However, by 15 days PI, these larger vessels
again remodeled into smaller, more numerous capillaries.
Surprisingly, even without the initial inclusion of 10T1/2
cells, the vessels within the implant stained positive for a-
SMA, suggesting that pericyte-like cells are recruited to the
implant from host circulation upon anastomosis and estab-
lishment of blood flow. This finding is consistent with pre-
vious studies, which illustrate that circulating perivascular
progenitor cells contribute to tumor angiogenesis.25 To-
gether, these results imply that the presence of 10T1/2s does
not impact the overall vascularization effect in our system,
but rather the timeline of maturation from large vessels to
smaller stable capillaries.
Previous studies indicate that ECs of different origins
exhibit different vascularization responses in vivo.15 In this
study, we demonstrated that clinically relevant cell types
such as HMVECs and iPS ECs induced a similar vascular-
ization response to HUVECs upon implantation in vivo.
Again, without a supporting mural cell, implanted cords
containing HMVECs and iPS ECs formed a few large ves-
sels at 7 days which later reorganized into smaller, more
numerous capillaries by 14 days. It was also apparent that
iPS ECs had a slight advantage over other cell types in the
total volume of blood. Because the vascularization effect is
similar among these different EC types, our system can be
customized by using patient-specific (syngeneic) endothelial
cells. Taken together, our findings that cords can support
vascularization with a range of endothelial cell sources and
stoichiometries also might provide sufficient flexibility to
allow for the customization of engineered tissue with tissue-
specific endothelial cells, or sourcing focused on more ac-
cessible tissues (e.g., skin), as well as variation in the ratios
of parenchymal cells, supporting cells, and endothelial cells
depending on the context. Whether cords composed of tis-
sue-specific ECs could provide better support for specific
parenchyma in this approach remains to be seen.
We also demonstrate our ability to pattern parenchymal
cells within the cords themselves. In our previous studies,
hepatocytes were seeded into a fibrin matrix either without
exogenous ECs or in the bulk of the matrix surrounding
cords, leaving a large fraction of parenchymal cells outside
the predicted perfusion zone of the cords.6 In this study,
hepatocytes and ECs contracted together to form cords,
keeping the parenchymal cells in close proximity to the host
vascularization response. Furthermore, coculturing ECs and
hepatocytes within cords led to sorting of the cell types
within the cords with ECs forming a sheath around a he-
patocyte core. These studies are in their infancy, and future
studies to elucidate the effects of scaling the size of im-
plants, as well as the paracrine and juxtacrine signaling ef-
fects of the two cell types within these conformations and
their effects on functional outputs such as albumin and urea
will be necessary for clinical applications. The patterning
approach offered here will add to others26 to allow the study
and optimization of such effects using multiple cell and
tissue types in vitro to inform future in vivo studies. Ulti-
mately, the ability to control vascular architecture using
methods demonstrated here will enable studies of the effects
of vascular features such as vessel density, alignment, and
branching on tissue oxygenation and function and will in-
form the next generation of custom tissue-specific vascular
architectures.
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